Jan 04, 2017 10:07am EST NeuroRx announces FDA IND clearance for NRX-101 phase 2b/3 study and publication of promising biomarker data
Oct 18, 2016 6:00am EDT NeuroRx solidifies Intellectual Property Position - receives notice of Allowance by US Patent Office
Sep 07, 2016 8:30am EDT NeuroRx Announces Participation At The 18th Annual Rodman & Renshaw Global Investment Conference In New York City September 11-13, 2016
Oct 21, 2015 11:04am EDT American Psychiatric Association Task Force Report Identifies Potential Value of NeuroRx Active Ingredient for Treatment of Depression
Jun 24, 2015 1:00pm EDT NeuroRx Announces First Human Trial Results Targeting Sustained Treatment of Bipolar Depression & Suicidality
